Respiratory / Generic (single ingredient)       
Duasma HFA MDI
Made up of Budesonide corticosteroid drugs, Duasma HFA MDI, having acquired the medical certification in Taiwan was launched and began to compete in the market in 2013. With a market size of over $800million,it is currently the only kind of inhaled corticosteroid drugs available for pregnant women, principally against asthma disease.